title: Angiotensin converting enzyme inhibitors, thiazide diuretics and magnesium balance. A preliminary study.
abstract: Serum and mononuclear cell magnesium content were determined in a cross-sectional study performed in four groups of hypertensive patients on chronic treatment with atenolol (n = 11), enalapril (n = 10), thiazide diuretics (n = 12), or enalapril + thiazides (n = 11). Our study shows that in patients treated with the thiazides alone, in spite of normal serum potassium and magnesium levels, mononuclear cell magnesium was decreased. To the extent that mononuclear Mg content mirrors the body ion stores, our results indicate that thiazides induce a Mg depletion not detectable by monitoring serum levels.
authors: Department of Medical Therapeutics, S. Orsola University Hospital, Bologna, Italy.
authors: P L
authors: PL
authors: Malini
authors: E
authors: E
authors: Strocchi
authors: G
authors: G
authors: Valtancoli
authors: E
authors: E
authors: Ambrosioni
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D001262:Atenolol / Q000008:administration & dosage / Q000009:adverse effects; D001581:Benzothiadiazines; D004232:Diuretics; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism; D008274:Magnesium / Q000097:blood*; D008275:Magnesium Deficiency / Q000097:blood / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D001262:Atenolol; D004656:Enalapril; D008274:Magnesium